FIGURE

Fig. 3

ID

ZDB-FIG-230516-22

Publication

Chen et al., 2022 - TGS1 impacts snRNA 3'-end processing, ameliorates survival motor neuron-dependent neurological phenotypes in vivo and prevents neurodegeneration

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Tgs1 down-regulation in zebrafish leads to defects in CaP-MNs. (A) Lateral views of whole-mount embryos immunostained with a synaptotagmin antibody (Znp1) that labels the CaP-MNs. Embryos were untreated or injected with the indicated MOs. Injection of either tgs1 ATG-MO or tgs1 Sp-MO results in truncated or absent motor axons (solid arrowheads) and terminally branched axons (open arrowheads). Scale bar, 25 μm. See also Supplementary Figure S2. (B) Based on overall appearance, CaP-MNs were classified as: normal, short (truncated axonal projection) or absent (axonal atrophy). Based on terminal branching, axons were classified as normal, mild (branching ventral from midline), intermediate (2–3 or more branches at ventral or midline) or severe (>3 branches ventral or dorsal from the midline). Zebrafish larvae injected with 1.5 ng of tgs1 Sp-MO or 2 ng tgs1 ATG-MO displayed CaP-MN defects compared with control (non-targeting) MOs and uninjected fish. Results are percentages from three independent experiments (n = axons analysed; N = animals tested. ****P < 0.0001 χ² test); n.s. not significant. See also Supplementary Figure S2D.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nucleic Acids Res.